Cart
sales@molnova.com
PIK-293
CAS No. 900185-01-5
PIK-293( PIK-293 | PIK 293 | PIK293 )
Catalog No. M17650 CAS No. 900185-01-5
PIK-293 is a?PI3K?inhibitor, for?PI3Kδ( IC50=0.24 μM), and less potent for PI3Kα/β/ γ.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 67 | In Stock |
|
| 5MG | 110 | In Stock |
|
| 10MG | 177 | In Stock |
|
| 25MG | 312 | In Stock |
|
| 50MG | 464 | In Stock |
|
| 100MG | 662 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePIK-293
-
NoteResearch use only, not for human use.
-
Brief DescriptionPIK-293 is a?PI3K?inhibitor, for?PI3Kδ( IC50=0.24 μM), and less potent for PI3Kα/β/ γ.
-
DescriptionPIK-293 is a?PI3K?inhibitor, for?PI3Kδ( IC50=0.24 μM), and less potent for PI3Kα/β/ γ.
-
In Vitro——
-
In Vivo——
-
SynonymsPIK-293 | PIK 293 | PIK293
-
PathwayMAPK/ERK Signaling
-
TargetJNK
-
Recptorp110α| p110β| p110γ| p110δ
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number900185-01-5
-
Formula Weight397.43
-
Molecular FormulaC22H19N7O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (125.81 mM)
-
SMILESCc1c2c(ccc1)nc(n(c2=O)c1ccccc1C)Cn1c2c(cn1)c(ncn2)N
-
Chemical Name2-((4-amino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-5-methyl-3-o-tolylquinazolin-4(3H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Knight ZA et al. Cell, 2006, 125(4), 733-747.
molnova catalog
related products
-
c-JUN peptide
Peptide comprising residues 33 - 57 of the JNK binding (δ) domain of human c-Jun. Disrupts JNK/c-Jun interaction leading to inhibition of serum-induced c-Jun phosphorylation, up-regulation of p21cip/waf and modulation of inflammatory gene expression. Specifically induces apoptosis in HeLa tumor cells.
-
Caffeic Acid
Caffeic Acid is an orally bioavailable, hydroxycinnamic acid derivative and polyphenol, with potential anti-oxidant, anti-inflammatory, and antineoplastic activities.
-
JNK-IN-8
JNK-IN-8 is a potent, selective, pan-JNK inhibitor with IC50 of 4.7 nM, 18.7 nM and 1 nM for JNK1, JNK2 and JNK3, respectively.
